APA (7th ed.) Citation

V, G., C, H., M, L., R, M., M, R., S, A., . . . AP, R. (2025). Nirsevimab Effectiveness Against RSV-Related Hospitalisations in Children Under 24 Months: A Test-Negative Case-Control Study in Portugal, 2024-2025. Influenza and other respiratory viruses, 19(12), e70186. https://doi.org/10.1111/irv.70186

Chicago Style (17th ed.) Citation

V, Gaio, et al. "Nirsevimab Effectiveness Against RSV-Related Hospitalisations in Children Under 24 Months: A Test-Negative Case-Control Study in Portugal, 2024-2025." Influenza and Other Respiratory Viruses 19, no. 12 (2025): e70186. https://doi.org/10.1111/irv.70186.

MLA (9th ed.) Citation

V, Gaio, et al. "Nirsevimab Effectiveness Against RSV-Related Hospitalisations in Children Under 24 Months: A Test-Negative Case-Control Study in Portugal, 2024-2025." Influenza and Other Respiratory Viruses, vol. 19, no. 12, 2025, p. e70186, https://doi.org/10.1111/irv.70186.